This inventor holds 3 USPTO granted patents and 1 published patent application. Top assignees: X-Cutag Therapeutics, Inc., University of Massachusetts. Active years: 2006-2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2006-2020
Title: Hui Joyce Li: Innovator in Cancer Treatment
Introduction
Hui Joyce Li is a prominent inventor based in Westborough, MA (US). She has made significant contributions to the field of pharmaceuticals, particularly in developing innovative compounds for treating various diseases. With a total of 3 patents, her work focuses on addressing critical health challenges.
Latest Patents
Hui Joyce Li's latest patents include groundbreaking research on fluorine- and/or deuterium-containing compounds for treating non-small cell lung cancer and related diseases. This patent describes novel fluoride and/or deuterium-containing chemical compounds that are useful for treating cancer or related disorders, along with pharmaceutical compositions and methods of preparation and use. Another significant patent involves deuterated compounds for treating Fabry, Gaucher, Parkinson's, and related diseases. This patent presents novel deuterium-containing chemical compounds that act as glucosylceramide (GSC) synthase inhibitors, which are beneficial for treating various types of lysosomal storage diseases, including Fabry's disease, Gaucher's disease, and Parkinson's disease.
Career Highlights
Throughout her career, Hui Joyce Li has worked with notable organizations such as X-Cutag Therapeutics, Inc. and the University of Massachusetts. Her experience in these institutions has allowed her to advance her research and contribute to the development of effective treatments for serious health conditions.
Collaborations
Hui Joyce Li has collaborated with esteemed colleagues, including Changfu Cheng and Shuhao Wen. These partnerships have fostered a collaborative environment that enhances innovation and research in her field.
Conclusion
Hui Joyce Li's contributions to pharmaceutical innovations demonstrate her commitment to improving health outcomes through her inventive work. Her patents reflect a dedication to addressing complex medical challenges, particularly in cancer and lysosomal storage diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile